Q1 2024 Seer Inc Earnings Call Transcript
Key Points
- Seer Inc (SEER) continues to expand its commercial team and invest in strategic initiatives to drive adoption and awareness of the Proteograph Product Suite.
- The company has launched additional Sphere Technology Access Centers in Europe to provide comprehensive services from sample to data, enhancing accessibility for European customers.
- Seer Inc (SEER) has implemented a share repurchase program for up to $25 million, reflecting confidence in the long-term value of the company's platform.
- The company has seen multiple customers purchase instruments through the Strategic Instrument Placement (SIP) program, validating the value and quality of the Proteograph.
- Seer Inc (SEER) has a strong pipeline of customer publications forthcoming in high-impact journals, which is expected to drive further adoption and utilization of the Proteograph platform.
- First quarter revenue of $3.1 million indicates a decrease from the previous year, with Seer Inc (SEER) facing headwinds to adoption of the Proteograph Product Suite.
- The company has revised its 2024 revenue expectations to $16 million to $18 million, indicating challenges in achieving a significant revenue inflection.
- Seer Inc (SEER) is experiencing elongated sales cycles and pressure on CapEx budgets, affecting the outright purchase of new instrumentation.
- The company has implemented a 10% reduction in force outside of the commercial organization to reduce capital use until revenue growth accelerates.
- Despite ongoing efforts, the pace of adoption and utilization of the Proteograph platform is not yet on track with the company's expectations.
Good day and thank you for standing by, and welcome to the Seer, Inc. First Quarter 2024 earnings conference call. (Operator Instructions)
Again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Carrie Mendivil, Investor Relations. Please go ahead.
Thank you. Earlier today, Seer released financial results for the quarter ended March 31st, 2024. If you have not received the news release or if you'd like to be added to the Company's distribution list, it's an e-mail to investor at cirrus dot. Joining me today from Seer is Omnitracs side, Chief Executive Officer and Chair, and David Hart, President and Chief Financial Officer.
Before we begin, I'd like to remind you that management will make statements during this call that are forward looking statements within the meaning of federal securities laws. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
